Lemonade's transition from a growth-focused insurtech darling to a disciplined, mature insurer is unfolding. The company has shifted its strategy to emphasise operational efficiency and a lower gross loss ratio,...
Retail investors often find themselves in a paradoxical environment where the promise of community is undercut by zero-sum thinking and hostility. This atmosphere stifles their potential, which could be better...
UnitedHealth Group is poised to exceed $400 billion in revenue, yet faces significant margin pressures due to rising medical costs and integration challenges, not to mention a cyberattack. The company's...
PayPal's potential path to a share price over $100 hinges on achieving mid-single-digit revenue growth and boosting net margins to 16% by 2026. While this bullish scenario is mathematically appealing,...
The concentration of wealth among the world’s elite has more than doubled since 2020, leaving five billion people economically adrift. Corporate power enables firms to suppress wages while boosting shareholder...
In London's bustling King’s Cross, the world of pharmaceutical science is being revolutionised by artificial intelligence, collapsing drug discovery timelines from years to months. The area’s vibrant "Knowledge Quarter" attracts...
The US healthcare sector, particularly UnitedHealth Group, is currently enveloped in investor pessimism, evoking memories of the 2023 regional banking crisis. This might just be an opportunity in disguise as...
The Chinese e-commerce battleground has shifted from easy growth to a fierce competition for value-focused consumers. Pinduoduo's explosive success and global expansion have reshaped the market, leaving Alibaba and JD.com...
Delve into the realm of stocks under £20 billion, where firms like Tempus AI and Rocket Lab redefine the forefront of disruptive industries. While these companies promise thrilling potential in...
The US government's unexpected $27 billion budget surplus in June stems predominantly from a surge in tariff revenues, creating an illusion of fiscal health rather than a true economic shift....
